meso-scale topologies for functional networks in biomedical applications. J.Math.Ind. 1:6 doi:10.1186/2190-5983-1-6 B.M.Schuldt, F.J.Müller, A.Schuppert, (2012): What can networks do for you? In: New frontiers [...] Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors PLoS One [2013, 8(1):e53668] PMID:23326482 PMCID:PMC3541187 [...] l Medicine, https://doi.org/10.1002/sctm.18-0180 Computing for Health Care Winter, A. et al., (2018) Smart Medical Information Technology for Healthcare (SMITH), Methods Inf Med 2018; 57(S 01): e92-e105

Scholarship Council (CSC) stipend for Mr. Liangliang Lia from Shanghai Xiaotong University 2023 – 2026 Funding of the German Research foundation for development of novel carriers for nucleic acids 2023 – 2024 [...] state of NRW for establishing explant cultures ( NovoKolon - ZukunftBio.NRW ) 2022 – 2026 BMBF funding for replacing animal experiments 2022 - 2026 China Scholarship Council (CSC) stipend for Mr. Liangliang [...] Uptake of the different particles quantified b ICP-MS. (D) Representative plots for the application of flow cytometry for quantification of the cells which migrated to the bottom of the Boyden chamber.

In recent years, additional roles (beneficial ones as well as detrimental ones) for mast cells have become obvious. For instance, mast cells protect from bacterial peritonitis, are involved in the development [...] receptor tyrosine kinase, c-Kit (CD117), and the Toll-like receptor 4 (TLR4 = receptor for lipopolysaccharide) are central for differential mast cell activity in health and disease. The analyses of respective [...] usually induce pro-inflammatory responses, for instance the production of the cytokines IL-6, TNF-α and IL-1β. One of the best studied TLRs is TLR4, the receptor for LPS (endotoxin) from gram-negative bacteria

personalized interventions that can improve health outcomes for patients. Our ultimate goal is to develop sustainable and effective strategies for preventing and treating gastrointestinal (GI) and metabolic [...] system-level approaches to uncover new therapeutic targets for hepatic steatosis without increasing plasma lipids and thus CVD risk. Our ideal target for MASLD therapy would reduce liver lipid accumulation and [...] national and international collaborators. Sustainability Planetary health is a prerequisite for individual health. For us as scientists and clinicians, it is imperative to spread awareness: We need to limit

survival rates, respectively. Breast cancer stem cells (BCSCs) are hypothesized to play a crucial role for the tumorbiological behavior of TNBC with the high metastatic potential as well as the observed metastatic [...] in an orthotopic xenograft (Fig. 2) from as few as a 1000 cells making these cells the ideal basis for our multiple projects: Differentiation therapy targeting breast cancer stem cells KDM4 Inhibition targets [...] microRNA expression in breast cancers and their potential as prognostic and predictive biomarkers for innovative neoadjuvant therapeutic options With breast cancer still affecting about one third of the

DFG, keynote scientific speakers and a podium discussion with participating CRC speakers Specific for PhD/MD students & postdocs: DFG-organized information session with possibility to reserve individual [...] Where? Kap Europa Kongresshaus der Messe Frankfurt Osloer Str. 5 60327 Frankfurt am Main, Germany For whom? Members of the participating collaborative research consortia and everyone interested in cardiac

Mittwoch, 23. November: Gesundheitskiosk 17:00 bis 18:00 Uhr Center for Teaching and Training CT², Forckenbeckstr. 71, 52074 Aachen Der Gesundheitskiosk Aachen ist ein niederschwelliges Beratungsangebot

Experimentelle Forschungsprojekte der Klinik für Thorax-, Herz- und Gefäßchirurgie.

Increase national cooperation and exchange of expertise on scientific, technological and training level. FOR WHOM? Members of the participating SFB consortia as well as all other interested researchers in the

Die Schwerpunkte der Aachener Ataxie-Ambulanz liegen bei den hereditären Kleinhirnerkrankungen, der autosomal rezessiv vererbten Friedreich Ataxie (FRDA) und den autosomal dominant vererbten spinocerebellären Ataxien (SCAs).